Biogen Idec Announces Webcast of Presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference, will be webcast live via the internet, on February 7, 2008 at 1:40 pm ET. To access the live webcast, please visit Biogen Idec’s homepage, www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.
About Biogen Idec
Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit http://www.biogenidec.com.
Heidi Brewster, 877-420-2442